发明授权
US07199231B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof
失效
编码肿瘤排斥抗原前体MAGE-4和41的分离的核酸分子及其用途
- 专利标题： Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof
- 专利标题（中）： 编码肿瘤排斥抗原前体MAGE-4和41的分离的核酸分子及其用途
-
申请号： US09579543申请日： 2000-05-26
-
公开(公告)号： US07199231B1公开(公告)日： 2007-04-03
- 发明人: Béatrice Guagler , Benoit van den Eynde , Pierre van der Bruggen , Thierry Boon-Falleur
- 申请人： Béatrice Guagler , Benoit van den Eynde , Pierre van der Bruggen , Thierry Boon-Falleur
- 申请人地址： US NY New York
- 专利权人： Ludwig Institute for Cancer Research
- 当前专利权人： Ludwig Institute for Cancer Research
- 当前专利权人地址： US NY New York
- 代理机构： Fulbright & Jaworski LLP
- 主分类号： C07H21/04
- IPC分类号： C07H21/04 ; C07H1/00 ; C07H5/04 ; C07H5/06 ; C07H19/00
摘要：
The invention relates to nucleic acid molecules which code for the tumor rejection antigen precursor MAGE-4 and 41. Also disclosed are vectors, cell lines, and so forth, which utilize the nucleic acid molecule, and optionally, molecules coding for human leukocyte antigen HLA-A1. Use of these materials in therapeutic and diagnostic contexts are also a part of the invention.
信息查询
